<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Comments on: Pharma Layoffs Continue</title>
	<atom:link href="http://blog.pharmexec.com/2009/03/04/pharma-layoffs-continue/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmexec.com/2009/03/04/pharma-layoffs-continue/</link>
	<description>The Business of Pharmaceuticals</description>
	<lastBuildDate>Wed, 08 Feb 2012 14:53:10 -0500</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Kisky</title>
		<link>http://blog.pharmexec.com/2009/03/04/pharma-layoffs-continue/comment-page-1/#comment-45058</link>
		<dc:creator>Kisky</dc:creator>
		<pubDate>Thu, 01 Oct 2009 19:08:30 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmexec.com/?p=656#comment-45058</guid>
		<description>Trubion develops protein therapeutic products for autoimmune and inflammatory diseases and cancer.

We&#039;ll see the results.</description>
		<content:encoded><![CDATA[<p>Trubion develops protein therapeutic products for autoimmune and inflammatory diseases and cancer.</p>
<p>We&#8217;ll see the results.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

